Persistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variants
Vadrevu, Krishna Mohan, Ganneru, Brunda, Reddy, Siddharth, Jogdand, Harsh, Raju, Dugyala, Sapkal, Gajanan, Yadav, Pragya, Reddy, Prabhakar, Verma, Savita, Singh, Chandramani, Redkar, Sagar Vivek, Gillurkar, Chandra Sekhar, Kushwaha, Jitendra Singh, Mohapatra, Satyajit, Bhate, Amit, Rai, Sanjay Kumar, Ella, Raches, Abraham, Priya, Prasad, Sai, Ella, Krishna
Published in Scientific reports (14.07.2022)
Published in Scientific reports (14.07.2022)
Get full text
Journal Article
Th1 skewed immune response of whole virion inactivated SARS CoV 2 vaccine and its safety evaluation
Ganneru, Brunda, Jogdand, Harsh, Daram, Vijaya Kumar, Das, Dipankar, Molugu, Narasimha Reddy, Prasad, Sai D., Kannappa, Srinivas V., Ella, Krishna M., Ravikrishnan, Rajaram, Awasthi, Amit, Jose, Jomy, Rao, Panduranga, Kumar, Deepak, Ella, Raches, Abraham, Priya, Yadav, Pragya D., Sapkal, Gajanan N., Shete-Aich, Anita, Desphande, Gururaj, Mohandas, Sreelekshmy, Basu, Atanu, Gupta, Nivedita, Vadrevu, Krishna Mohan
Published in iScience (23.04.2021)
Published in iScience (23.04.2021)
Get full text
Journal Article
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial
Ella, Raches, Vadrevu, Krishna Mohan, Jogdand, Harsh, Prasad, Sai, Reddy, Siddharth, Sarangi, Vamshi, Ganneru, Brunda, Sapkal, Gajanan, Yadav, Pragya, Abraham, Priya, Panda, Samiran, Gupta, Nivedita, Reddy, Prabhakar, Verma, Savita, Kumar Rai, Sanjay, Singh, Chandramani, Redkar, Sagar Vivek, Gillurkar, Chandra Sekhar, Kushwaha, Jitendra Singh, Mohapatra, Satyajit, Rao, Venkat, Guleria, Randeep, Ella, Krishna, Bhargava, Balram
Published in The Lancet infectious diseases (01.05.2021)
Published in The Lancet infectious diseases (01.05.2021)
Get full text
Journal Article
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial
Ella, Raches, Reddy, Siddharth, Jogdand, Harsh, Sarangi, Vamshi, Ganneru, Brunda, Prasad, Sai, Das, Dipankar, Raju, Dugyala, Praturi, Usha, Sapkal, Gajanan, Yadav, Pragya, Reddy, Prabhakar, Verma, Savita, Singh, Chandramani, Redkar, Sagar Vivek, Gillurkar, Chandra Sekhar, Kushwaha, Jitendra Singh, Mohapatra, Satyajit, Bhate, Amit, Rai, Sanjay, Panda, Samiran, Abraham, Priya, Gupta, Nivedita, Ella, Krishna, Bhargava, Balram, Vadrevu, Krishna Mohan
Published in The Lancet infectious diseases (01.07.2021)
Published in The Lancet infectious diseases (01.07.2021)
Get full text
Journal Article
Immunogenicity and reactogenicity of an inactivated SARS-CoV-2 vaccine (BBV152) in children aged 2–18 years: interim data from an open-label, non-randomised, age de-escalation phase 2/3 study
Vadrevu, Krishna Mohan, Reddy, Siddharth, Jogdand, Harsh, Ganneru, Brunda, Mirza, Nizam, Tripathy, Virendra Nath, Singh, Chandramani, Khalatkar, Vasant, Prasanth, Siddaiah, Rai, Sanjay, Ella, Raches, Blackwelder, William, Prasad, Sai, Ella, Krishna
Published in The Lancet infectious diseases (01.09.2022)
Published in The Lancet infectious diseases (01.09.2022)
Get full text
Journal Article
Evaluation of Safety and Immunogenicity of an Adjuvanted, TH-1 Skewed, Whole Virion InactivatedSARS-CoV-2 Vaccine - BBV152
Ganneru, Brunda, Jogdand, Harsh, Dharam, Vijaya Kumar, Narasimha Reddy Molugu, Prasad, Sai D, Vellimudu, Srinivas, Ella, Krishna M, Rajaram Ravikrishnan, Awasthi, Amit, Jomy Jose, Rao, Panduranga, Kumar, Deepak, Raches Ella, Abraham, Priya, Yadav, Pragya, Sapkal, Gajanan N, Shete, Anita, Gururaj Rao Desphande, Mohandas, Sreelekshmy, Basu, Atanu, Gupta, Nivedita, Vadrevu, Krishna Mohan
Published in bioRxiv (12.09.2020)
Published in bioRxiv (12.09.2020)
Get full text
Paper